Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1095 of 5804
-
Ear zap during heart surgery may ward off Post-Op delirium
Symptom relief Not yet recruitingA multicenter, randomized, double-blind, sham-controlled trial to investigate the effects of intraoperative transcutaneous auricular vagus nerve stimulation (taVNS) on the incidence of postoperative delirium and negative emotional states (anxiety, depression) in patients undergoi…
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study is an open-label, multi-center Phase IB/II clinical trial of SHR-9839(sc) combined with anti-tumor therapy in patients with advanced solid tumors, aimed at evaluating the safety, tolerability, and efficacy of SHR-9839(sc) in combination with anti-tumor therapy in patie…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a simple pill stop Post-Surgery sickness? new trial aims to find out
Prevention Recruiting nowPostoperative nausea and vomiting (PONV) are a frequent and debilitating complications after surgery, affecting up to 80% of patients at high risk in the absence of prophylaxis. Despite the rigorous application of the recommendations from the American Society of Anesthesiologist…
Phase: PHASE3 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New drug hopes to shrink tumors in patients out of options
Disease control Recruiting nowThis study is open to adults with advanced germ cell tumours, endometrial cancer, or ovarian cancer whose previous treatments were not successful. People can join the study if they have no remaining treatment options or if standard therapy is not suitable. The purpose of this stu…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can blood tests predict stroke risk in silent atrial fibrillation?
Knowledge-focused Recruiting nowThe purpose of this observational study is to investigate whether blood tests related to blood clotting are associated with established clinical stroke risk scores, the total amount of device-detected atrial fibrillation recorded by an implanted cardiac device, and ultrasound mea…
Sponsor: Andreas Sjøholm-Christensen • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
VR relaxation offers new hope for burn survivors battling chronic pain and itch
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New hope for stomach cancer patients who have run out of options?
Disease control Not yet recruitingThis study aims to evaluate the safety and tolerability of JPI-547 in combination with irinotecan as a third-line and beyond therapy for recurrent or metastatic gastric cancer
Phase: PHASE1, PHASE2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New shot shows promise for diabetes and weight loss in india
Disease control Recruiting nowThe main purpose of this study is to measure the safety and efficacy of tirzepatide in adult participants in India who have type 2 diabetes or who have obesity or overweight without type 2 diabetes. Participation in the study will last about 46 weeks.
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a daily supplement fight chemobrain? new study investigates
Symptom relief ENROLLING_BY_INVITATIONThe goal of this research protocol is to evaluate whether supplementation with: synbiotics (probiotics with agave inulin), synbiotics with vitamid D or prebiotics (agave inulin) can reduce cognitive decline in patients with breast cancer undergoing neoadjuvant chemotherapy. It wi…
Phase: NA • Sponsor: Instituto Jalisciense de Cancerologia • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New scan could spot hidden prostate cancer spread
Diagnosis Recruiting nowThe goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumor tissue. The main question it aims to answer is how this information can be used to better diagnose and track prostate c…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New drug cocktail aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowAn Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour.
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Digital platform aims to Fine-Tune heart failure drugs after hospital stay
Disease control Recruiting nowDigiCare-HFrEF is an investigator-initiated, multicentre, randomised, open-label, endpoint-blinded, superiority trial designed to evaluate whether a structured digital remote-management platform can optimise guideline-directed medical therapy (GDMT) in patients with heart failure…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New immune cell therapy aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study is being done to assess the safety and determine the maximum tolerable dose (MTD) of TCRαβ+/CD19+-depleted Donor Lymphocyte Infusion (αβT/B dep-DLI) after allogeneic stem cell transplant (allo-SCT) in highrisk patients with hematologic malignancies.
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a smaller dose of nutrients protect kids from malnutrition?
Prevention Recruiting nowNutrition is essential for a child's growth, brain development, and protection from disease. While breastmilk provides the best nutrition for young infants, children older than six months may not get all the nutrients they need from breastmilk and regular foods alone. For this re…
Phase: NA • Sponsor: Aga Khan University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New hope for chronic UTI sufferers: extended antibiotic combo trial launches
Disease control Recruiting nowChronic Urinary Tract Infection (UTI) is a type of UTI where symptoms are constant and occur every day, unlike recurrent UTIs, which come and go with symptom-free breaks in between. Current treatment for chronic UTI within the NHS is based on recommended guidelines for recurrent …
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a supplement and meditation lift mild depression in teens?
Symptom relief Recruiting nowThe primary goal is to investigate to what extent changes in glutamate and glutathione modulation and functional integration between brain networks associated with emotion and attention regulation are associated with treatment response in mildly depressed youth.
Phase: PHASE3 • Sponsor: University of Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could fewer shots prevent rabies? new trial tests simpler vaccine schedules
⭐️ VACCINE ⭐️ OngoingA total of 3,000 participants will be enrolled, stratified by age into two groups: 600 participants aged 10-17 years and 2,400 participants aged 18-60 years. Within each age group, participants will be randomly assigned in a 1:1:1:1:1 ratio to one of five vaccination schedule gro…
Phase: PHASE3 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
AI reads heart scans to catch hidden disease earlier
Diagnosis Recruiting nowThe purpose of this study is to deploy and evaluate informational AI-Echo algorithms that assist echo clinicians in interpreting core echocardiographic parameters (e.g., LV/RV size and function, valvular disease severity) and stratifying disease progression risk. The primary outc…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Simple DNA test could predict bladder cancer recurrence
Diagnosis Recruiting nowBladder cancer is a highly heterogeneous malignancy characterized by frequent genetic alterations that are closely associated with disease progression, recurrence risk, and treatment response. However, existing mutation detection approaches are often limited by high cost, complex…
Sponsor: Zhilong Dong • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Fiber fuel: could your diet boost melanoma treatment?
Knowledge-focused Not yet recruitingThe underlying hypothesis of the study is that melanoma patients treated with immunotherapy, whether in an adjuvant or curative setting, who consume more fiber would respond better to immunotherapy: either no recurrence in the case of adjuvant treatments, or no progression (disea…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC